Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 18Fflutemetamol PET/CT Imaging of Transthyretin Cardiac Amyloidosis (Flutemetamol-ATTR Study No ClinicalTrials.gov identifier reported
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy NCT04018053
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy NCT04018053
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy NCT04018053
- 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy NCT04018053
- 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study NCT05707182
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05125302
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) No ClinicalTrials.gov identifier reported
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04647214
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05601882
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05127954
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT03671148
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05439616
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05216250
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04578756
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04903626
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT06012240
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04401748
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05216263
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT04647214
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) NCT05291234
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) NCT04647214
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) NCT04647214
- 18Sust033 No ClinicalTrials.gov identifier reported
- 18US-FHp04/A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries No ClinicalTrials.gov identifier reported
- 19-006003 Predictors and effect of biofeedback intervention on the severity of glucocorticoid withdrawal syndrome after curative surgery in patients with endogenous Cushing No ClinicalTrials.gov identifier reported
- 19-010887 MC1821 MCR Lead Site Docetaxel plus Bintrafusp alfa or placebo for NSCLC No ClinicalTrials.gov identifier reported
- 19-0339 No ClinicalTrials.gov identifier reported
- 19-0339_R No ClinicalTrials.gov identifier reported
- 19-05519-055 No ClinicalTrials.gov identifier reported
- 19-06-001 No ClinicalTrials.gov identifier reported
- 19-12021159 No ClinicalTrials.gov identifier reported
- 1923 Voclosporin in Alport Syndrome (PI Dr. Alessia Fornoni) No ClinicalTrials.gov identifier reported
- 1924-703-007 XEN45 Ab-Ex Study (M21-507) NCT05411198
- 19-395 No ClinicalTrials.gov identifier reported
- 193-C-21-USA-002-V01 No ClinicalTrials.gov identifier reported
- 19-568_R No ClinicalTrials.gov identifier reported
- 19-651 NCT04273139
- 19-743 No ClinicalTrials.gov identifier reported
- 19920 20186 DMC Chair agreement/ Dr. Bjornstad No ClinicalTrials.gov identifier reported
- 19-Avp-786-108 No ClinicalTrials.gov identifier reported
- 19-Avp-786-108, 19-Avp-786-109, 19-Avp-786-110, 19-Avp-786-111, 19-Avp-786-112, 19-Avp-786-113 No ClinicalTrials.gov identifier reported
- 19-Avp-786-109 No ClinicalTrials.gov identifier reported
- 19-Avp-786-110 No ClinicalTrials.gov identifier reported
- 19-Avp-786-111 No ClinicalTrials.gov identifier reported
- 19-Avp-786-112 No ClinicalTrials.gov identifier reported
- 19Sust053 No ClinicalTrials.gov identifier reported
- 19Sust057 No ClinicalTrials.gov identifier reported
- 19th IHIWS NEXA No ClinicalTrials.gov identifier reported
- 1) A Method to Assess Fetal Cardiac Function in Labor 2) the Efficacy of Using the Angle of Progression (Aop) Through Trans- Perineal Ultrasound (Tpu) to Predict Vaginal Delivery No ClinicalTrials.gov identifier reported